These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Activity of (1-benzyl-4-triazolyl)-indole-2-carboxamides against Toxoplasma gondii and Cryptosporidium parvum. Khan SM; Garcia Hernandez A; Allaie IM; Grooms GM; Li K; Witola WH; Stec J Int J Parasitol Drugs Drug Resist; 2022 Aug; 19():6-20. PubMed ID: 35462232 [TBL] [Abstract][Full Text] [Related]
3. Novel acyl carbamates and acyl / diacyl ureas show in vitro efficacy against Toxoplasma gondii and Cryptosporidium parvum. Li K; Grooms GM; Khan SM; Hernandez AG; Witola WH; Stec J Int J Parasitol Drugs Drug Resist; 2020 Dec; 14():80-90. PubMed ID: 33011650 [TBL] [Abstract][Full Text] [Related]
4. In Vitro and In Vivo Activities of Tilmicosin and Acetylisovaleryltylosin Tartrate against Ma Y; Cao X; Wang H; Song X; Hu D Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076987 [No Abstract] [Full Text] [Related]
5. Nullscript inhibits Cryptosporidium and Toxoplasma growth. Murakoshi F; Bando H; Sugi T; Adeyemi OS; Nonaka M; Nakaya T; Kato K Int J Parasitol Drugs Drug Resist; 2020 Dec; 14():159-166. PubMed ID: 33120250 [TBL] [Abstract][Full Text] [Related]
6. Stable expression of mucin glycoproteins GP40 and GP15 of Cryptosporidium parvum in Toxoplasma gondii. Li M; Sun X; Chen H; Li N; Feng Y; Xiao L; Guo Y Parasit Vectors; 2024 Feb; 17(1):65. PubMed ID: 38360646 [TBL] [Abstract][Full Text] [Related]
7. Apicomplexan parasites are attenuated by low-energy electron irradiation in an automated microfluidic system and protect against infection with Toxoplasma gondii. Finkensieper J; Mayerle F; Rentería-Solís Z; Fertey J; Makert GR; Lange F; Besecke J; Schopf S; Poremba A; König U; Standfest B; Thoma M; Daugschies A; Ulbert S Parasitol Res; 2023 Aug; 122(8):1819-1832. PubMed ID: 37233817 [TBL] [Abstract][Full Text] [Related]
14. A conserved coccidian gene is involved in Toxoplasma sensitivity to the anti-apicomplexan compound, tartrolon E. Bowden GD; Reis PM; Rogers MB; Bone Relat RM; Brayton KA; Wilson SK; Di Genova BM; Knoll LJ; Nepveux V FJ; Tai AK; Ramadhar TR; Clardy J; O'Connor RM Int J Parasitol Drugs Drug Resist; 2020 Dec; 14():1-7. PubMed ID: 32738587 [TBL] [Abstract][Full Text] [Related]
15. Stable expression of Cryptosporidium parvum glycoprotein gp40/15 in Toxoplasma gondii. O'Connor RM; Wanyiri JW; Wojczyk BS; Kim K; Ward H Mol Biochem Parasitol; 2007 Apr; 152(2):149-58. PubMed ID: 17275106 [TBL] [Abstract][Full Text] [Related]
16. Promising Esboei BR; Keighobadi M; Hezarjaribi HZ; Fakhar M; Daryani A; Chabra A; Soosaraei M; Yalveh R Infect Disord Drug Targets; 2021; 21(1):151-155. PubMed ID: 32389115 [TBL] [Abstract][Full Text] [Related]
17. Two small-molecule inhibitors of Hua QQ; Lin XJ; Xiang SP; Jiang LY; Cai JH; Sun JM; Tan F; Mou YN Front Cell Infect Microbiol; 2023; 13():1145824. PubMed ID: 37077525 [TBL] [Abstract][Full Text] [Related]
18. Mitochondrial dysfunction induced by bedaquiline as an anti-Toxoplasma alternative. Shi Y; Jiang Y; Qiu H; Hu D; Song X Vet Res; 2023 Dec; 54(1):123. PubMed ID: 38115043 [TBL] [Abstract][Full Text] [Related]
19. During host cell traversal and cell-to-cell passage, Toxoplasma gondii sporozoites inhabit the parasitophorous vacuole and posteriorly release dense granule protein-associated membranous trails. Tartarelli I; Tinari A; Possenti A; Cherchi S; Falchi M; Dubey JP; Spano F Int J Parasitol; 2020 Nov; 50(13):1099-1115. PubMed ID: 32882286 [TBL] [Abstract][Full Text] [Related]
20. Polyether ionophore kijimicin inhibits growth of Toxoplasma gondii and controls acute toxoplasmosis in mice. Leesombun A; Nihei CI; Kondoh D; Nishikawa Y Parasitol Res; 2022 Jan; 121(1):413-422. PubMed ID: 34750652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]